Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 6, 2026

Safety of prescribed drug use among pregnant women attending antenatal care in Midwestern Brazil: A cross-sectional study.

View Full Paper
Ask AI
Bookmark
Share

Authors

KOKethleen S D OliveiraUniversidade de Rio VerdeBRBruna Tainah RuyUniversidade de Rio VerdeCCCarine F CorreaUniversidade de Rio Verde

Discussion

Loading...

Member takes

Implication

A cross-sectional study assesses medication safety in pregnant women, highlighting implications for prescribing practices.

Key Points

  • The aim is to evaluate the safety of prescribed medications for pregnant women in Midwestern Brazil considering FDA categories and PLLR.
  • Reviewed medical records of pregnant women in a university outpatient clinic in Goiânia, Brazil.
  • Recorded patient characteristics, prescribed medications, and trimester of use.
  • Classified each drug by FDA categories and assessed PLLR information.
  • 81.7% of women received at least one prescription, primarily during the first trimester.
  • Most frequent prescriptions were supplements (38.6%), analgesics/anti-inflammatory (26.6%), and gastrointestinal agents (17.0%).
  • FDA categorization showed 14.6% A, 41.5% B, 29.3% C, and 7.3% D drugs.
  • Under PLLR, 41.5% of drugs had complete information, with data gaps for many prescriptions.

Cite This Study

Oliveira et al. (2026) studied this question.

synapsesocial.com/papers/69aa7096531e4c4a9ff5a885https://doi.org/10.1177/09246479261432738
View Full Paper
Ask AI
Bookmark
Share